Search

everythinglearnresearchcommunity

for

Search:↓

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Stem cells help heal skin wounds by moving and changing roles, working with other cells, and needing more research on their activation and behavior.

Hyaluronidase speeds up wound healing and reduces inflammation.

Hair follicles can help wounds heal faster and this knowledge could be used to treat chronic skin ulcers, with a potential use of a special stem cell hydrogel to enhance healing.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Lgr5 is a marker for active, self-renewing stem cells in the intestine and skin, important for tissue maintenance.

New treatments for male hypogonadism are effective and should be personalized.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Mice without collagen VI have slower hair growth normally but faster regrowth after injury.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Targeting colon cancer stem cells might lead to better treatment results.

Early development of hair, teeth, and glands involves specific signaling pathways and cellular interactions.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.